Plain-English translation of NCT05760898 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Hypertension research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is designed to help people who have both rheumatoid arthritis and high blood pressure. You'll receive a home blood pressure monitor and learn how to use it correctly, then track your readings several times a week for 3 months. The goal is to understand what makes it hard for people with rheumatoid arthritis to control their blood pressure, so doctors can better protect their hearts.
People with rheumatoid arthritis have a higher risk of heart disease, and high blood pressure is a major factor that's often not well controlled in this group. This study aims to identify and overcome the barriers that make blood pressure management difficult for these patients.
You likely qualify if…
You likely don't qualify if…
You'll take your blood pressure at home at least three times per week using a monitor provided by the study. Every 2 weeks over the 3-month study period, you'll send your readings to the research team and complete a short survey about your rheumatoid arthritis symptoms, pain, medications, and any challenges you face in managing your blood pressure. The study team will help you learn how to use the monitor correctly and understand what your readings mean.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
United States
Sponsor
Duke University
Collaborators
National Institute on Minority Health and Health Disparities (NIMHD)
Enrollment target
~25 participants
Started
January 2026
Primary completion
December 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in February 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Isaac Smith, MD
Duke University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.